Testing effectiveness (Phase 2)Study completedNCT01556594
What this trial is testing
Safety and Efficacy of a Novel Glucagon Formulation in Type 1 Diabetic Patients Following Insulin-induced Hypoglycemia
Who this might be right for
Hypoglycemia
Eli Lilly and Company 18